Xenazine and acute myeloid leukaemia recurrent Patient Reports February 12, 2012

Xenazine Side Effects Report #6077973-7
Xenazine side effect was reported by a Health Professional from ITALY on Jan 27, 2009. Male patient was diagnosed with huntington's chorea and was treated with Xenazine. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, blood glucose increased, blood sodium decreased, blood urea increased, blood uric acid decreased, oesophagitis, sepsis . Xenazine dosage: (37.5 MG QD). During the same period patient was treated with SERENASE, ROCEPHIN, PERFALGAN, LOSEC, INEXIUM, LANSOX, MINITRAN, SELEPARINA. Patient was hospitalized. Patient died on 12/05/2008.

Xenazine Side Effects Report #6096942-4
Xenazine side effect was reported by a Health Professional from ITALY on Feb 10, 2009. Male patient was diagnosed with huntington's chorea and was treated with Xenazine. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, blood alkaline phosphatase increased, blood glucose increased, blood urea increased, blood uric acid decreased, duodenal ulcer, laboratory test abnormal, oesophagitis, platelet count decreased. Xenazine dosage: (37.5 MG QD). During the same period patient was treated with SERENASE, ROCEPHIN, PERFALGAN, OMEPRAZEN, INEXIUM, LANSOX, MINITRAN, SELEPARINA. Patient was hospitalized. Patient died on 12/05/2008.